TopBP1 a sweet spot for treatment in multiple cancers
2014-11-17
(Press-News.org) HOUSTON -- (Nov. 17, 2014) - A compound called calcein may act to inhibit topoisomerase IIβ-binding protein 1 (TopBP1), which enhances the growth of tumors, said researchers from Baylor College of Medicine in a report that appears online in the journal Nature Communications.
"The progression of many solid tumors is driven by de-regulation of multiple common pathways," said Dr. Weei-Chin Lin, associate professor of medicine- hematology & oncology, and a member of the NCI-designated Dan L. Duncan Cancer Center at Baylor. Among those are the retinoblastoma (Rb), PI(3)K/Akt and p53 pathways, which, when de-regulated, lead to accumulation and structural alteration of TopBP1.
Previously topoisomerase IIβ-binding protein 1 had been shown by Lin's lab to suppress apoptosis (programmed cell death) in cancer by repressing E2F1 and to mediate effects of p53 mutations. (TP53 is a tumor suppressor gene). When it is mutated or missing, it cannot prevent the formation of tumors. Moreover, mutant p53 proteins gain new functions in promoting cancer progression, and these activities in part depend on TopBP1.)
In studies in cell culture and in mice, Lin and his colleagues at Baylor showed that calcein inhibits these activities of TopBP1.
Here the authors identify calcein as a lead compound to inhibit TopBP1 and show that calcein has anti-tumor activity in mouse cancer models.
A topoisomerase is a class of enzymes that control the number and topology of supercoils in DNA. Type I enzymes cut one DNA strand, rotate it about the other, and reseal the ends. Type II enzymes cut and reseal both ends. TopBP1 is a protein that binds the enzyme.
INFORMATION:
Others who took part in this work include Pinki Chowdhury, Gregory E. Lin, Kang Liu, Yongcheng Song and Fang-Tsyr Lin, all of Baylor. Gregory Lin is also with Rice University.
Funding for this work came from National Institutes of Health Grants RO1CA100857, RO1CA138641 to W.-C.L., and ARRA 3 P30CA125123-03S5), Department of Defense Breast Cancer Research Program (Grant W81XWH-14-1-0339), Department of Defense Ovarian Cancer Research Program (Grant W81XWH-14-1-0306) to W.-C.L. and F.-T.L. and the National Institute of Neurological Disorders and Stroke (Grant R01NS080963) to Y.S.
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-17
A study led by researchers at University of Helsinki, Finland and Universities of Melbourne and South Australia has identified a new gene for a progressive form of epilepsy. The findings of this international collaborative effort have been published today, 17 November 2014, in Nature Genetics.
Progressive myoclonus epilepsies (PME) are rare, inherited, and usually childhood-onset neurodegenerative diseases whose core symptoms are epileptic seizures and debilitating involuntary muscle twitching (myoclonus). The goal of the international collaborative study was to identify ...
2014-11-17
Scientists have found that altering members of the p53 gene family, known as tumor suppressor genes, causes rapid regression of tumors that are deficient in or totally missing p53. Study results suggest existing diabetes drugs, which impact the same gene-protein pathway, might be effective for cancer treatment.
The University of Texas MD Anderson Cancer Center investigation showed that, in vivo, the genes p63 and p73 can be manipulated to upregulate or increase levels of IAPP, a protein important for the body's ability to metabolize glucose. IAPP is found in some diabetes ...
2014-11-17
BALTIMORE, MD - As the world's diminishing fresh water resources are increasing allocated for human use, agricultural and horticultural production operations must rely more often on the use of brackish, saline, or reclaimed water for irrigation. These saline-rich water sources often contain electrical conductivities that can negativity affect plants' ability to thrive. Salinity is particularly problematic for ornamental plants such as daffodils because of the potential for damage to plants' aesthetics and visual qualities.
In the September 2014 issue of HortScience, Maren ...
2014-11-17
ROCHESTER, Minn. -- One of the family of drugs prescribed for rheumatoid arthritis and other inflammatory conditions is called TNF inhibitors. They act by dampening part of the immune system called tumor necrosis factor (TNF). In one of the balancing acts of medicine, the anti-inflammatory action of the drug also increases the risk for other conditions, in this case, a rare form of eye cancer, uveal melanoma. Mayo Clinic researchers make the case and alert physicians in an article in Mayo Clinic Proceedings.
Mayo researchers studied three patients -- two women and a ...
2014-11-17
Who says your kids don't listen to you?
An Indiana University study has found that setting specific family rules about healthy eating and sedentary behavior actually leads to healthier practices in children.
Data analyzed for the study was originally part of a data set used to evaluate the Wellborn Baptist Foundation's HEROES program, a K-12 school-based obesity prevention initiative set in the Illinois, Indiana and Kentucky tri-state area. However, lead author Alyssa M. Lederer, doctoral candidate and associate instructor in the Department of Applied Health Science ...
2014-11-17
CINCINNATI--Researchers at the University of Cincinnati (UC) have found that a gene abundant in the kidneys may actually play a role in the regulation of blood pressure and hypertension in experimental male mouse models.
The study led by Manoocher Soleimani, MD, James F. Heady Professor of Medicine and associate chair of research in the Department of Internal Medicine at UC, was presented during the annual meeting of the American Society of Nephrology, held Friday, Nov. 15, 2014, in Philadelphia.
The gene, a kidney androgen-regulated protein (KAP) that is abundantly ...
2014-11-17
New Rochelle, NY, November 17, 2014--In the future, as space exploration takes astronauts on longer missions and more female astronauts participate, "The Impact of Sex and Gender on Adaptation to Space" will become increasingly critical to astronaut safety and mission success, as explored in a special collection of articles published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The articles are available Open Access on the Journal of Women's Health website at http://online.liebertpub.com/toc/jwh/23/11.
In the Executive ...
2014-11-17
LOGAN, UT - Urban landscape plants are often subjected to environmental conditions well beyond those of their native habitat. Differences in precipitation, along with stress caused by increased salinity resulting from irrigation with brackish reclaimed water, can have devastating impacts on trees and plants. Use of salt-tolerant species and implementation of proper management strategies can reduce the incidence of plant stress and loss. Researchers in Utah looked to plants' native habitats for ways to identify salt tolerance among tree species used in urban landscapes in ...
2014-11-17
An international team of scientists led by Uppsala University has developed a high-throughput method of imaging biological particles using an X-ray laser. The images show projections of the carboxysome particle, a delicate and tiny cell compartment in photosynthetic bacteria.
The experiment, described in a paper published today in the scientific journal Nature Photonics, represents a major milestone for studies of individual biological structures using X-ray lasers. The technique paves the way for 3D imaging of parts of the cell, and even small viruses, to develop a ...
2014-11-17
November 17, 2014 - A growing body of research evidence shows that complementary and alternative medicine (CAM) has health benefits for US military veterans and active duty personnel, according to a special December supplement to Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
The special issue presents new studies and commentaries on the benefits and increasing use of CAM techniques in the Veterans Health Administration (VHA) and other military health settings. "The papers in this supplement represent promising ...
LAST 30 PRESS RELEASES:
[Press-News.org] TopBP1 a sweet spot for treatment in multiple cancers
